Prelude Therapeutics (PRLD)

0.71

-0.05 (-6.46%)

At close: Mar 03, 2025, 3:59 PM

0.68

-3.25%

After-hours: Mar 03, 2025, 04:00 PM EST

Prelude Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-121.83M	-115.44M	-111.69M	-56.93M	-27.57M	-14.68M
Depreciation & Amortization	1.17M	1.32M	915K	542K	382K	149K
Stock-Based Compensation	25.62M	25.14M	20.93M	5.58M	846K	180K
Other Working Capital	-8.21M	1.28M	-278K	3.46M	121K	661K
Other Non-Cash Items	-1.54M	4.31M	1.33M	11K	10K	15K
Deferred Income Tax	n/a	n/a	1.36M	n/a	n/a	n/a
Change in Working Capital	-10.48M	932K	3.63M	4.62M	667K	1.38M
Operating Cash Flow	-107.06M	-83.73M	-83.53M	-46.18M	-25.66M	-12.95M
Capital Expenditures	-3.51M	-3.02M	-2.32M	-621K	-780K	-529K
Acquisitions	n/a	-84.71K	n/a	n/a	n/a	n/a
Purchase of Investments	-221.63M	-119.22M	-261.48M	n/a	n/a	n/a
Sales Maturities Of Investments	190.5M	203.93M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	84.71K	-261.48K	n/a	n/a	n/a
Investing Cash Flow	-34.65M	81.69M	-263.8M	-621K	-780K	-529K
Debt Repayment	n/a	n/a	n/a	-258K	-124K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.34M	815K	3.47M	79.86M	29.85M	17.94M
Financial Cash Flow	136.4M	815K	164.9M	246.23M	29.73M	17.94M
Net Cash Flow	-5.31M	-1.22M	-182.44M	199.43M	3.28M	4.45M
Free Cash Flow	-110.58M	-86.75M	-85.85M	-46.8M	-26.45M	-13.48M